High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes.

about

Standardisation of minimal residual disease in multiple myeloma.Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.Molecular detection of minimal residual disease in multiple myeloma.

P2860

Q39410899-CF901C96-9EA8-4AB9-90BE-E657F4834FD0 Q42050819-A5DBAAC2-EBD8-4BD1-81E7-13DC6D475637 Q48371783-2FBCF28F-A6D7-4B01-BCA3-900E9D04F324

P2860

High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes.

Item

http://www.wikidata.org/entity/Q42385408

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

High applicability of ASO-RQPC ...... tient-specific primers/probes.

@en

High applicability of ASO-RQPC ...... tient-specific primers/probes.

@nl

type

Item

label

High applicability of ASO-RQPC ...... tient-specific primers/probes.

@en

High applicability of ASO-RQPC ...... tient-specific primers/probes.

@nl

prefLabel

High applicability of ASO-RQPC ...... tient-specific primers/probes.

@en

High applicability of ASO-RQPC ...... tient-specific primers/probes.

@nl

P1476

High applicability of ASO-RQPC ...... atient-specific primers/probes

@en

P2093

Kwan Yeung Wong

http://www.w3.org/2001/XMLSchema#string

Tsz Kin Fung

http://www.w3.org/2001/XMLSchema#string

Yinlei Bai

http://www.w3.org/2001/XMLSchema#string

P2860

New criteria for response assessment: role of minimal residual disease in multiple myeloma

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

Assessment of IgH PCR strategies in multiple myeloma.

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease.

Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.

P2888

s13045-016-0336-4

P304

107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-016-0336-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

CS Chim

P577

2016-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017240857

http://www.w3.org/2001/XMLSchema#string

P698

27724958

http://www.w3.org/2001/XMLSchema#string

P932

5057274

http://www.w3.org/2001/XMLSchema#string

High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes.

about

P2860

P2860

High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932